Neumora Therapeutics, Inc. (NMRA) › Capital ExpendituresNeumora Therapeutics, Inc. (NMRA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2022: $511.0K2023: $117.0K$117.0K2022Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$117.0K-77.1%2022$511.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share